U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Cancer Institute (NCI) - Thursday, May 3, 2007

CONTACT: NCI Office of Media Relations, 301-496-6641, e-mail: ncipressofficers@mail.nih.gov

An advanced imaging technique known as electron tomography has allowed researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to visualize an "entry claw," a unique structure formed between the human immunodeficiency virus (HIV) that causes AIDS and the cell it infects. The findings are in the May 4, 2007, issue of "PLoS Pathogens".

"Visualizing the molecular mechanisms by which HIV and related viruses enter their host cells can potentially lead to the identification of novel drugs," said NIH Director Elias A. Zerhouni, M.D.

Retroviruses such as HIV establish contact and enter their target cells via an interaction between proteins on the surface of the virus (called spikes) and specific host cell membrane receptors. Previous studies have suggested that several spikes and several cell receptors are involved in every virus infection event. The findings of the NCI research team, led by Sriram Subramaniam, Ph.D., Laboratory of Cell Biology at NCI's Center for Cancer Research, demonstrate that this is true, but in a surprising way.

"This elegant research not only gives us insights into how HIV and related viruses interact with proteins on the surface of cells and then enter the host cells to integrate their DNA, it also gives us important clues as to how to design improved anti-HIV therapy," said NCI Director John E. Niederhuber, M.D. "Electron tomography and other new tools for imaging at the single-cell or subcellular level also have the potential to help us actually see the subcellular effects of many different diseases -- including cancer -- that we could only guess at previously."

In this study, the scientists showed that the interaction actually takes the form of a tight cluster of five to seven rod-shaped features. This striking and unexpected arrangement was dubbed the "entry claw" by the researchers (see figure below). They also found that the arrangement of spikes across the rest of the virus seems to largely disappear upon formation of the entry claw, suggesting a shedding event that has not previously been noted, which may have some, still uncertain relevance to infectivity.

"The discovery of the entry claw raises many fundamental questions about viral entry into host cells," said Subramaniam. "What are its precise molecular components? How does the viral genetic core actually transfer to the host cell? What are the other intermediate steps of the entry claw formation and can they be visualized? As we continue to improve the technology, we believe we will answer these and other related questions."

Traditional imaging techniques based on light microscopy do not offer sufficient resolution to see how cellular molecules and small structures interact in actual life, and powerful techniques such as X-ray crystallography can only define the structure of an individual molecule or simple molecular interactions. Electron tomography and related methods for 3D electron microscopy can fill this imaging gap and reveal fine subcellular structures or virus-host interactions in great detail. The Subramaniam lab has been pioneering advances in 3D electron microscopy, and is applying the emerging technologies to understanding not only virus-host interactions, but also visualizing such things as structures inside the cell that distinguish cancer cells from normal cells.

Graphics depicting contact of HIV-1 with a T-cell:

Contact of HIV-1 with T-cells. Electron tomographic analysis (left) reveals the architecture of the virus-cell contact region which forms an “entry claw” as shown in the schematic (right). Scale bar in left panel is 100 nanometers wide.

For more information on this work and the Subramaniam laboratory's work in high resolution electron microscopy, go to http://hrem.nci.nih.gov.

For more information about cancer, please visit the NCI website at http://www.cancer.gov, or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).

The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

----------------------

REFERENCE: Sougrat R, Bartesaghi A, Lifson JD, Bennett AD, Bess J, Zabransky DJ, Subramaniam S. Electron tomography of the contact between T-cells and SIV/HIV-1: Implications for viral entry. "PLoS Pathogens". May 4, 2007.

070503
NIH070501

Published 2007 - The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research. All material contained in this report is in the public domain and may be used and reprinted without special permission; citation to source, however, is appreciated.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .